Highlights From This Issue October 3, 2019 From The Carlat Psychiatry Report Issue Links: Learning Objectives | Editorial Information | PDF of Issue Quick hits on what you’ll find in this issue.Read More
FDA Approves a Hormonal Injection for Low Libido in Women October 3, 2019 Chris Aiken, MD From The Carlat Psychiatry Report Issue Links: Learning Objectives | Editorial Information | PDF of Issue Vyleesi is FDA approved for low libido in women, but its modest benefits and significant risks give us pause.Read More
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
Psychology and Social WorkTreating BPD Series, Episode 2: Transference-Focused Psychotherapy—From Splitting to Coherence with Frank Yeomans, MD, PhD In this episode, Dr. Frank Yeomans offers a deep dive into the theory and clinical practice of TFP as a treatment for Borderline Personality Disorder. Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
